Federated Hermes, Inc. Acer Therapeutics Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$2.47 - $4.39 $281,804 - $500,859	-114,091 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.34 - $2.99 $8,381 - $10,710	-3,582 Reduced 3.04%	114,091 $299,000
Q3 2020 Nov 12, 2020	SELL	$2.16 - $5.41 $61,395 - $153,773	-28,424 Reduced 19.46%	117,673 $339,000
Q2 2020 Aug 13, 2020	BUY	$1.53 - $4.53 $86,180 - $255,161	56,327 Added 62.75%	146,097 $501,000
Q1 2020 May 13, 2020	BUY	$1.18 - $5.86 $29,707 - $147,531	25,176 Added 38.98%	89,770 $179,000
Q4 2019 Feb 14, 2020	BUY	$2.85 - $4.2 $174,924 - $257,783	61,377 Added 1907.9%	64,594 $259,000
Q3 2019 Nov 14, 2019	BUY	$1.95 - $3.93 $6,273 - $12,642	3,217 New	3,217 $10,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.